Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Docetaxel 4Cetuximab 4pembrolizumab 3Trastuzumab 3Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Biopsy 3trastuzumab deruxtecan 2sargramostim 2Taxes 2SS1(dsFv)PE38 2Radiotherapy 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Carboplatin 2Capecitabine 2zanidatamab 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1tanespimycin 1spartalizumab 1pertuzumab 1oncogene protein E7, Human papillomavirus type 16 1neratinib 1mercaptoundecahydrododecaborate 1larotrectinib 1fluoromisonidazole 1entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × oncogene protein E7, Human papillomavirus type 16 × Gastrointestinal × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡